Literature DB >> 20442303

Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression.

Hye Won Jeon1, You Mie Lee.   

Abstract

Hypoxia is a strong signal for cell migration and invasion in cancer. The reversion-inducing cysteine-rich protein with Kazal motif (RECK), a tumor suppressor, inhibits cancer cell migration and invasion and is frequently silenced in aggressive tumor cells by histone deacetylases (HDAC). However, the effect of RECK silencing in several cancer cells in a hypoxic microenvironment has not been fully delineated. In this report, we investigated whether hypoxia suppressed RECK expression and used HDAC inhibitor (HDACI) inhibition to restore RECK expression to inhibit cancer cell migration and invasion. HDACIs, including trichostatin A (TSA), completely rescued RECK expression, which was suppressed by hypoxia, in the H-Ras-transformed human breast MCF10A and the HT1080 cell lines (human fibrosarcoma). TSA suppressed the activity of matrix metalloproteinase-2 (MMP-2) and MMP-9, induced by hypoxia, and significantly inhibited hypoxia-stimulated migration and invasion of both cancer cells. RECK overexpression significantly inhibited the migration and invasion of cancer cells induced by hypoxia. The hypoxic effect on the migration and invasion of cells was equivalent to the effect seen using the small interfering RNA (siRNA) of RECK under normoxia, suggesting an inhibitory role for RECK in hypoxic conditions. We also showed that siRNA silencing of HDAC1 suppressed hypoxia-induced RECK downregulation and inhibited the migration and invasion of cancer cells. In conclusion, the inhibition of HDAC successfully restored the expression of RECK under hypoxic conditions. This resulted in the inhibition of cancer cell migration and invasion through the repression of MMP-2 and MMP-9 activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442303     DOI: 10.1158/1535-7163.MCT-09-0717

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  22 in total

Review 1.  Fetal hypoxia and programming of matrix metalloproteinases.

Authors:  Wenni Tong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

2.  Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression.

Authors:  J Zhang; X Qin; Q Sun; H Guo; X Wu; F Xie; Q Xu; M Yan; J Liu; Z Han; W Chen
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

3.  Hypoxia-inducible factor-1α regulates KCNMB1 expression in human pulmonary artery smooth muscle cells.

Authors:  Yong-Tae Ahn; Yu-Mee Kim; Eloa Adams; Shu-Chen Lyu; Cristina M Alvira; David N Cornfield
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-11-23       Impact factor: 5.464

4.  Promoter hypermethylation of the RECK gene is associated with its low expression and poor survival of esophageal squamous cell carcinoma.

Authors:  Jing Zhu; Yang Ling; Yun Xu; Mingzhu Lu; Yongping Liu; Changsong Zhang
Journal:  Oncol Lett       Date:  2017-01-27       Impact factor: 2.967

5.  Concurrent alterations of RAGE, RECK, and MMP9 protein expression are relevant to Epstein-Barr virus infection, metastasis, and survival in nasopharyngeal carcinoma.

Authors:  Dong-Ni Zhou; Yan-Fei Deng; Rong-Hua Li; Ping Yin; Chun-Sheng Ye
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 6.  Epigenetic regulation of mmp-9 gene expression.

Authors:  Marilyne Labrie; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2012-11-27       Impact factor: 9.261

7.  Role of matrix metalloproteinases and histone deacetylase in oxidative stress-induced degradation of the endothelial glycocalyx.

Authors:  Mohamed M Ali; Abeer M Mahmoud; Elizabeth Le Master; Irena Levitan; Shane A Phillips
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-01-11       Impact factor: 4.733

8.  The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma.

Authors:  Changsong Zhang; Yang Ling; Chenghui Zhang; Yun Xu; Lu Gao; Rong Li; Jing Zhu; Lieying Fan; Lixin Wei
Journal:  Int J Biol Sci       Date:  2012-03-03       Impact factor: 6.580

9.  Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.

Authors:  Hsuan-Heng Yeh; Yu-Fen Tseng; Yu-Chiao Hsu; Sheng-Hui Lan; Shan-Ying Wu; Giri Raghavaraju; Da-En Cheng; Ying-Ray Lee; Tsuey-Yu Chang; Nan-Haw Chow; Wen-Chun Hung; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2015-03-25       Impact factor: 4.430

10.  RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch.

Authors:  L A Walsh; D M Roy; M Reyngold; D Giri; A Snyder; S Turcan; C R Badwe; J Lyman; J Bromberg; T A King; T A Chan
Journal:  Oncogene       Date:  2014-06-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.